<div class="raw-html-embed"> Newsletteraktion: Abonnieren Sie jetzt unseren Newsletter und sichern Sie sich bis zum 8. August 2025 10% Rabatt auf Ihre Onlinebestellungen. <a href="/newsletter">Infos und Anmeldung.</a></div>

NL_Doormat: Hintergrundfarbe des Newsletter Banners unten in der Doormat. Mit # eingeben z.B. #1405BE

NL_Doormat: Verlinkung zur Newsletter Seite

Über uns

À propos de nous

Nachhaltigkeit

Durabilité

Open Access

Karriere

Carrière

Datenschutz

Protection des données

Impressum

Mentions légales

Zahlung und Lieferung

Paiement et livraison

LEXIA

LEXIA Arbeitsrecht

Was ist LEXIA?

C'est quoi LEXIA ?

LEXIA Familienrecht

Zeitschriften

Revues

recht

Pflegerecht

ZBJV

forumpoenale

ZStrR

Anwaltsrevue

Revue de l'avocat

RSAS

FamPra.ch

ASYL

Life Science Recht

BlAR

Sachbuch

Livres spécialisés

LOKI

Semaphor

Fokusthemen

Focus

Thema

Recht studieren

Arbeitsrecht

Droit du travail

Studium

Études

Familienrecht

Droit de la famille

Sozialversicherungsrecht

Droit des assurances sociales

Strafrecht

Droit pénal

Publikationen

Publications

Literatur

Onlinemodule LEXIA

Modules en ligne LEXIA

Bücher

Livres

Buchreihen

Collections

Datenbanken

recht.ch

Studienliteratur

Littérature pour les études

Services

Dienstleistungen für

Corporate Books

Publishing Lösungen

Aktuelles

Geschäftskunden

Professionnels

Corporate Publishing

Content solutions

Buchhandlungen

Librairies

Veranstaltungen

Événements

Presse

Dozierende

Enseignants

Studierende

Étudiants

Inserierende

Annonceurs

Newsletter

Blog

Autorinnen/Autoren

Auteurs

Unsere Schreibenden

Hilfe

Unsere Autorinnen und Autoren

Liste

Autorenlounge

Espace des auteurs

Bei uns publizieren

Publier chez nous

Autorenstimmen

Témoignages

Verlag

Éditions

Themen

Mehr wissen

Mitarbeitende

Collaborateurs

Geschichte

Histoire

Vision und Mission

Vision et mission

Unser Magazin

Notre magazine

Unternehmenskultur

Culture d'entreprise

Partner

Partenaires

Kontakt

Contact

Shop

Schweizer Recht

Ausländisches Recht

Über unseren Shop

Neuerscheinungen

Nouveautés

Sortiment und Funktionen

Assortiment et recherche

Vorankündigungen

À paraître

Nach Rechtsgebiet

Par domaine juridique

Kommentare

Commentaires

Kornfeldt T: The Unnatural Selection of
Our Species

The Unnatural Selection of Our Species

At the Frontier of Gene Editing

Practical Bioinformatics

The Future of Human Evolution

The Creatures’ Guide to Caring

Cybersecurity for Healthcare Systems in the Internet of Medical Things Era

Impacts, Detection and its Remediation

Xenobiotics in Environment

Human Evolutionary Genetics

New York Times bestselling author and former FDA Commissioner Scott Gottlieb provides a glimpse of a promising future that is quickly approaching: a world with cures for chronic illnesses and cancers. While traditional drugs mostly help us manage the effects of disease, cell therapies promise genuine cures for a broad range of intractable ailments, from Alzheimer's to heart damage to cancer. They could even reverse the effects of aging. For the first time in history, on an unprecedented scale, we possess the power to modify the biology that gives rise to disease, ultimately restoring individuals to a state of normalcy and reversing debilitating ailments. In The Miracle Century, former FDA Commissioner Scott Gottlieb traces the scientific achievements that propelled progress in cell therapies. The birth of this medical revolution wasn't a sudden event. Rather, it emerged from decades of steady, incremental progress in science. These concerted advances made cell therapies a reality. To forge a path for continued medical breakthroughs, Dr. Gottlieb meticulously traces this scientific journey, identifying lessons on how these achievements can be replicated. The MIracle Century is a look at the future of healthcare from one of the nation's leading medical authorities. Scott Gottlieb explains how these new medicines are moving from the laboratory bench to the marketplace and tackles the issues that must be addressed to enable wide adoption of these treatments and transform as many lives as possible.

New York Times bestselling author and former FDA Commissioner Scott Gottlieb provides a glimpse of a promising future that is quickly approaching: a world with cures for chronic illnesses and cancers.While traditional drugs mostly help us manage the effects of disease, cell therapies promise genuine cures for a broad range of intractable ailments, from Alzheimer’s to heart damage to cancer. They could even reverse the effects of aging. For the first time in history, on an unprecedented scale, we possess the power to modify the biology that gives rise to disease, ultimately restoring individuals to a state of normalcy and reversing debilitating ailments.In The Miracle Century, former FDA Commissioner Scott Gottlieb traces the scientific achievements that propelled progress in cell therapies. The birth of this medical revolution wasn’t a sudden event. Rather, it emerged from decades of steady, incremental progress in science. These concerted advances made cell therapies a reality. To forge a path for continued medical breakthroughs, Dr. Gottlieb meticulously traces this scientific journey, identifying lessons on how these achievements can be replicated.The MIracle Century is a look at the future of healthcare from one of the nation’s leading medical authorities. Scott Gottlieb explains how these new medicines are moving from the laboratory bench to the marketplace and tackles the issues that must be addressed to enable wide adoption of these treatments and transform as many lives as possible.

Making Sense of the Cell Therapy Revolution

The Miracle Century

Applications and Challenges

Future of Internet of Bio-Nano Things in Personalized Healthcare

Applied Phycology

Polyphenol Nutraceuticals and Healthcare

Translational Epigenetics

Site Specific and Global Epigenomic Editing: Principles and Applications, Volume 33 highlights the expanding role that epigenetics plays in pathogenesis, the full range of sites for possible epigenetic modification, and the potential to target these sites to modulate disease progression. The book answers key questions, including which of the hundreds of epigenomic marks and features are relevant, and which are likely to serve a role in regulating gene expression, cell behavior and phenotypic outcomes. This volume is the first to provide a thorough, conceptual introduction to epigenetic regulation and a thorough accounting of sites for possible epigenetic edits and disease modulation. Included protocols and applied case studies examine early disease targets and likely pathways of therapeutic significance while also outlining common challenges in the field. The book addresses its topic in a comprehensive, but accessible manner, highlighting practical tools and burning questions remaining in the field to enable fresh research.

Principles and Applications

Site Specific and Global Epigenomic Editing: Volume 33

The Unnatural Selection of Our Species

Weitere Titel zum Thema